NovoRapid

NovoRapid Drug Interactions

insulin aspart

Manufacturer:

Novo Nordisk

Distributor:

Zuellig Pharma
Full Prescribing Info
Drug Interactions
A number of medicinal products are known to interact with glucose metabolism.
The following substances may reduce the patient's insulin requirements: Oral hypoglycaemic agents (OHAs), octreotide, monoamine oxidase inhibitors (MAOIs), nonselective β-adrenergic blocking agents, angiotensin-converting enzyme (ACE) inhibitors, salicylates, alcohol, anabolic steroids and sulfonamides.
The following substances may increase the patient's insulin requirements: Oral contraceptives, thiazides, glucocorticoids, thyroid hormones, sympathomimetics and danazol. β-Blocking agents may mask the symptoms of hypoglycaemia. Alcohol may intensify and prolong the hypoglycaemic effect of insulin.
Incompatibilities: Substances added to the insulin may cause degradation of the insulin eg, if the medicinal product contains thiol or sulphites.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in